STN-DBS has been claimed to change progressionsymptomsin animal models of PD but information is lacking about the possible neuromodulatory role of STN-DBS in humans. The aim of this prospective controlled study was to evaluate the long-term impact of STN-DBS on motor disabilities and cognitive impairment in PD patients in comparison to Best-Medical-Therapy BMT and Long-term-Post-Operative POP groups. "The potential neuromodulatory impact of subthalamic nucleus deep brain stimulation on Parkinsons disease progression."